NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Xxxxxxxxxx, XX 00000 Telephone: 000.000.0000 Facsimile: 202.205.0604 Healogics: Xxxxx X. Xxxxxxxxx EVP and Chief Compliance Officer Healogics, Inc. 0000 Xxxxxxx Xxxx, Xxxxx 000 Xxxxxxxxxxxx, XX 00000 Telephone: 000.000.0000 Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Healogics may be required to provide OIG with an electronic copy of each notification or report required by this CIA in addition to a paper copy.
NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 Dignity Health: Xxxxxxxx Xxxxxxxxx, MBA, CHC, CHPC Dignity Health 000 Xxxxx Xxxx Xxxxxx, 0xx xxxxx Xxxxxxxx, XX 00000 Telephone: 000.000.0000 Facsimile: 818.409.5266 Unless otherwise specified, all notifications and reports required by this CIA may be made by certified mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. For purposes of this requirement, internal facsimile confirmation sheets do not constitute proof of receipt. Upon request by OIG, Dignity Health may be required to provide OIG with an electronic copy of each Corporate Integrity Agreement Dignity Health notification or report required by this CIA in searchable portable document format (pdf), in addition to a paper copy.
NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 GSK: Xxxxxxx X. Xxxx Vice President & Compliance Officer North America Pharmaceuticals GlaxoSmithKline Three Franklin Plaza 000 X. 00xx Xxxxxx Xxxxxxxxxxxx, XX 00000 Telephone: 000.000.0000 Facsimile: 215.751.7547 Unless otherwise specified, all notifications and reports required by this CIA may be made by certified mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. For purposes of this requirement, internal facsimile confirmation sheets do not constitute proof of receipt. Upon request by OIG, GSK may be required to provide OIG with an electronic copy of each notification or report required by this CIA in searchable portable document format (pdf), either instead of or in addition to, a paper copy.
NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 Arc: Xxxx Xxxxxx, Corporate Compliance Officer 0000 Xxxx Xxxxx, Xxxxxxxxx XX 00000 Telephone: 000-000-0000 Facsimile: 000-000-0000 Unless otherwise specified, all notifications and reports required by this CIA shall be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Arc may be required to provide OIG with an electronic copy of each notification or report required by this CIA in addition to a paper copy.
NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 KDMC: Xxxx Xxxxxxxx VP, Corporate Compliance 0000 Xxxxxxxxx Xxxxxx Ashland, KY 41101 (000) 000-0000 (office) (000) 000-0000 (fax) Unless otherwise specified, all notifications and reports required by this CIA may be made by certified mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. For purposes of this requirement, internal facsimile confirmation sheets do not constitute proof of receipt. Upon request by OIG, KDMC may be required to provide OIG with an electronic copy of each notification or report required by this CIA in searchable portable document format (pdf), in addition to a paper copy.
NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 LWCI: Xxxxxxxxx Xxxx Lymphedema & Wound Care Institute 00000 Xxxxx Xxxx Xxxxxx Suite C-8 Houston, TX 77025 000-000-0000 xxxxx@xxxxxxxxxxxxxxxxxxx.xxx Unless otherwise specified, all notifications and reports required by this CIA may be made by certified mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. For purposes of this requirement, internal facsimile confirmation sheets do not constitute proof of receipt. Upon request by OIG, LWCI may be required to provide OIG with an electronic copy of each notification or report required by this CIA in searchable portable document format (pdf), in addition to a paper copy.
NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this IA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, XX Xxxxxxxxxx, XX 00000 Telephone: (000) 000-0000 Facsimile: (000) 000-0000 MPG: Xxxxxx Xxxx, M.D. Michigan Physicians Group, P.C. 0000 X. 00 Xxxx Xxxx Xxxxxxx, Xxxxxxxx 00000 Telephone: (000) 000-0000 Facsimile: (000) 000-0000 Email: xxxxxxx000@xxxxx.xxx Unless otherwise specified, all notifications and reports required by this IA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, MPG may be required to provide OIG with an additional copy of each notification or report required by this IA in OIG’s requested format (electronic or paper).
NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 Indivior: Xxxxx Xxxxxx Indivior Corporate Integrity Agreement Chief Integrity & Compliance Officer Indivior Inc. 00000 Xxxxxxxxxx Xxxxxxxx Xxxxx Xxxxxxxxxxxx, XX 00000 Telephone: 000-000-0000 Email: Xxxxx.xxxxxx@xxxxxxxx.xxx Unless otherwise specified, all notifications and reports required by this CIA may be made by electronic mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. Upon request by OIG, Indivior may be required to provide OIG with an additional copy of each notification or report required by this CIA in OIG’s requested format (electronic or paper).
NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Xxxxxxxxxx, XX 00000 Telephone: 000-000-0000 Facsimile: 000-000-0000 MCCG:
NOTIFICATIONS AND SUBMISSION OF REPORTS. Unless otherwise stated in writing after the Effective Date, all notifications and reports required under this CIA shall be submitted to the following entities: OIG: Administrative and Civil Remedies Branch Office of Counsel to the Inspector General Office of Inspector General U.S. Department of Health and Human Services Xxxxx Building, Room 5527 000 Xxxxxxxxxxxx Xxxxxx, X.X. Washington, DC 20201 Telephone: 000.000.0000 Facsimile: 202.205.0604 Novartis: Xxxxxxx Xxxxxx Vice President, Ethics & Compliance Novartis Pharmaceuticals Corporation Corporate Integrity Agreement (Chief Compliance Officer) Novartis Pharmaceuticals Corporation One Health Plaza East Hanover, NJ 00000-0000 Phone: 000.000.0000 Fax: 000.000.0000 Unless otherwise specified, all notifications and reports required by this CIA may be made by certified mail, overnight mail, hand delivery, or other means, provided that there is proof that such notification was received. For purposes of this requirement, internal facsimile confirmation sheets do not constitute proof of receipt. Upon request by OIG, Novartis may be required to provide OIG with an electronic copy of each notification or report required by this CIA in searchable portable document format (pdf), either instead of or in addition to, a paper copy.
